Investors on alert: ICICI Pru AMC and Wakefit set to unveil a massive Rs 13,000 crore IPO pipeline next week

DCM Editorial Summary: This story has been independently rewritten and summarised for DCM readers to highlight key developments relevant to the region. Original reporting by Economic Times, click this post to read the original article.

Next week, India’s primary market is set to experience a surge in activity, with 11 IPOs scheduled for subscription from December 8 to 17, aiming to raise approximately Rs 13,807 crore. Among these, the highly anticipated IPO of ICICI Prudential Asset Management is expected to be announced soon, likely on December 12. The IPO frenzy kicks off on December 8 with two mainboard offerings: Corona Remedies and Wakefit Innovations. Corona Remedies, a mid-sized pharmaceutical firm, will launch a Rs 655 crore offer priced between Rs 1,008 and Rs 1,062 per share. Meanwhile, Wakefit Innovations, a popular brand in the home solutions sector, will offer a Rs 1,289 crore IPO priced at Rs 185 to Rs 195 per share.

On December 10, the market will see an influx of three more IPOs: Nephrocare Health Services, Park Medi World, and Unisem Agritech. Nephrocare aims to raise Rs 871 crore with a price band of Rs 438 to Rs 460 per share, catering to the growing demand for dialysis services in India. Park Medi World plans to raise Rs 920 crore, while Unisem Agritech seeks Rs 21.45 crore. These three IPOs will close subscriptions on December 12. Additionally, Riddhi Display Equipments and two SME issues, Pajson Agro India and Unisem Agritech, will contribute to the week’s offerings.

The combined SME IPOs are expected to raise around Rs 208 crore. Investors are particularly keen on the upcoming announcement of ICICI Prudential AMC’s Rs 10,000 crore IPO, one of the largest in recent years. While the timing of this launch will depend on market conditions, it is anticipated to occur on December 12. Analysts note that the influx of IPOs reflects issuer confidence and a strong market appetite, although there are concerns about the potential impact of heavy supply amid foreign portfolio investors being net sellers. Despite recent record highs in the Nifty index, the narrow gains raise questions about the market’s capacity to absorb continued fundraising at this rate. However, the expectation of steady domestic liquidity and positive anchor book responses could help ensure that most mainboard issues succeed, leading to a busy conclusion for the 2025 IPO calendar.